mAbDx, Inc. is an immunodiagnostics company based in Eugene, OR, specializing in the development of rapid Point of Care tests for infectious diseases. With a focus on early diagnosis and prognosis, their innovative tests aim to revolutionize clinical practice by providing timely results that can significantly reduce morbidity and mortality, particularly in resource-limited settings.
Through their groundbreaking research and development, mAbDx has garnered recognition and funding from prestigious institutions such as the National Institute of Allergy and Infectious Diseases (NIAID) and the Oregon Business Development Department. Their expertise extends to various pathogens, including the marine bacterial pathogen Vibrio coralliilyticus and mitochondrial DAMPs involved in the Systemic Inflammatory Response Syndrome (SIRS). With a commitment to innovation and simplicity, mAbDx is at the forefront of advancing diagnostic tools for improved healthcare outcomes.
Generated from the website